Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Aug;72(2):469–475. doi: 10.1038/bjc.1995.357

Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials.

J F Tierney 1, V Mosseri 1, L A Stewart 1, R L Souhami 1, M K Parmar 1
PMCID: PMC2034002  PMID: 7640234

Abstract

Fifteen published randomised trials comparing adjuvant chemotherapy with no chemotherapy in soft-tissue sarcoma (STS) were identified (1546 patients). A qualitative review and a meta-analysis of this published literature were performed. With the qualitative review it was not possible to synthesise the apparently conflicting results of individual trials. The meta-analysis of the published data suggests an improvement in survival at 2 years (OR = 0.73, 95% CI = 0.53-0.99, P = 0.044) and at 5 years (OR = 0.59, 95% CI = 0.45-0.78, P = 0.0002) in favour of chemotherapy. However, the assumptions and approximations required to conduct this quantitative summary demand that the results are interpreted with caution. The only reliable means of assessing the current evidence on whether adjuvant chemotherapy has a role in the treatment of patients with STS, is to collect, check and reanalyse individual patients data (IPD) from each trial centrally, and formally combine the results in a stratified time-to-event analysis. Such an IPD analysis is currently being undertaken by an international collaborative group.

Full text

PDF
469

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvegård T. A., Sigurdsson H., Mouridsen H., Solheim O., Unsgaard B., Ringborg U., Dahl O., Nordentoft A. M., Blomqvist C., Rydholm A. Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol. 1989 Oct;7(10):1504–1513. doi: 10.1200/JCO.1989.7.10.1504. [DOI] [PubMed] [Google Scholar]
  2. Antman K., Suit H., Amato D., Corson J., Wood W., Proppe K., Harmon D., Carey R., Greenberger J., Blum R. Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups. J Clin Oncol. 1984 Jun;2(6):601–608. doi: 10.1200/JCO.1984.2.6.601. [DOI] [PubMed] [Google Scholar]
  3. Baker L. H., Frank J., Fine G., Balcerzak S. P., Stephens R. L., Stuckey W. J., Rivkin S., Saiki J., Ward J. H. Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613). J Clin Oncol. 1987 Jun;5(6):851–861. doi: 10.1200/JCO.1987.5.6.851. [DOI] [PubMed] [Google Scholar]
  4. Borden E. C., Amato D. A., Edmonson J. H., Ritch P. S., Shiraki M. Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas. Cancer. 1990 Sep 1;66(5):862–867. doi: 10.1002/1097-0142(19900901)66:5<862::aid-cncr2820660509>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  5. Bramwell V., Rouesse J., Steward W., Santoro A., Schraffordt-Koops H., Buesa J., Ruka W., Priario J., Wagener T., Burgers M. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 1994 Jun;12(6):1137–1149. doi: 10.1200/JCO.1994.12.6.1137. [DOI] [PubMed] [Google Scholar]
  6. Chang A. E., Kinsella T., Glatstein E., Baker A. R., Sindelar W. F., Lotze M. T., Danforth D. N., Jr, Sugarbaker P. H., Lack E. E., Steinberg S. M. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. J Clin Oncol. 1988 Sep;6(9):1491–1500. doi: 10.1200/JCO.1988.6.9.1491. [DOI] [PubMed] [Google Scholar]
  7. Delaney T. F., Yang J. C., Glatstein E. Adjuvant therapy for adult patients with soft tissue sarcomas. Oncology (Williston Park) 1991 Jun;5(6):105-18; discussion 118, 120, 123-4. [PubMed] [Google Scholar]
  8. Edmonson J. H., Fleming T. R., Ivins J. C., Burgert E. O., Jr, Soule E. H., O'Connell M. J., Sim F. H., Ahmann D. L. Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas. J Clin Oncol. 1984 Dec;2(12):1390–1396. doi: 10.1200/JCO.1984.2.12.1390. [DOI] [PubMed] [Google Scholar]
  9. Eilber F. R., Giuliano A. E., Huth J. F., Morton D. L. A randomized prospective trial using postoperative adjuvant chemotherapy (adriamycin) in high-grade extremity soft-tissue sarcoma. Am J Clin Oncol. 1988 Feb;11(1):39–45. doi: 10.1097/00000421-198802000-00009. [DOI] [PubMed] [Google Scholar]
  10. Elias A. D. Chemotherapy for soft-tissue sarcomas. Clin Orthop Relat Res. 1993 Apr;(289):94–105. [PubMed] [Google Scholar]
  11. Glenn J., Kinsella T., Glatstein E., Tepper J., Baker A., Sugarbaker P., Sindelar W., Roth J., Brennan M., Costa J. A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk. Cancer. 1985 Mar 15;55(6):1206–1214. doi: 10.1002/1097-0142(19850315)55:6<1206::aid-cncr2820550612>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  12. Glenn J., Sindelar W. F., Kinsella T., Glatstein E., Tepper J., Costa J., Baker A., Sugarbaker P., Brennan M. F., Seipp C. Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery. 1985 Mar;97(3):316–325. [PubMed] [Google Scholar]
  13. Kinsella T. J., Sindelar W. F., Lack E., Glatstein E., Rosenberg S. A. Preliminary results of a randomized study of adjuvant radiation therapy in resectable adult retroperitoneal soft tissue sarcomas. J Clin Oncol. 1988 Jan;6(1):18–25. doi: 10.1200/JCO.1988.6.1.18. [DOI] [PubMed] [Google Scholar]
  14. Lerner H. J., Amato D. A., Savlov E. D., DeWys W. D., Mittleman A., Urtasun R. C., Sobel S., Shiraki M. Eastern Cooperative Oncology Group: a comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma. J Clin Oncol. 1987 Apr;5(4):613–617. doi: 10.1200/JCO.1987.5.4.613. [DOI] [PubMed] [Google Scholar]
  15. Marsoni S., Torri W., Taiana A., Gambino A., Grilli R., Liati P., Franzosi M. G., Pistotti V., Parazzini F., Focarile F. Critical review of the quality and development of randomized clinical trials (RCTs) and their influence on the treatment of advanced epithelial ovarian cancer. Ann Oncol. 1990 Sep;1(5):343–350. doi: 10.1093/oxfordjournals.annonc.a057772. [DOI] [PubMed] [Google Scholar]
  16. Mazanet R., Antman K. H. Adjuvant therapy for sarcomas. Semin Oncol. 1991 Dec;18(6):603–612. [PubMed] [Google Scholar]
  17. Mertens W. C., Bramwell V. H. Adjuvant chemotherapy in the treatment of soft-tissue sarcoma. Clin Orthop Relat Res. 1993 Apr;(289):81–93. [PubMed] [Google Scholar]
  18. Nicolucci A., Grilli R., Alexanian A. A., Apolone G., Torri V., Liberati A. Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA. 1989 Oct 20;262(15):2101–2107. [PubMed] [Google Scholar]
  19. Omura G. A., Blessing J. A., Major F., Lifshitz S., Ehrlich C. E., Mangan C., Beecham J., Park R., Silverberg S. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol. 1985 Sep;3(9):1240–1245. doi: 10.1200/JCO.1985.3.9.1240. [DOI] [PubMed] [Google Scholar]
  20. Pinedo H. M., Bramwell V. H., Mouridsen H. T., Somers R., Vendrik C. P., Santoro A., Buesa J., Wagener T., van Oosterom A. T., van Unnik J. A. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group. Cancer. 1984 May 1;53(9):1825–1832. doi: 10.1002/1097-0142(19840501)53:9<1825::aid-cncr2820530904>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  21. Pinedo H. M., Verweij J. The treatment of soft tissue sarcomas with focus on chemotherapy: a review. Radiother Oncol. 1986 Mar;5(3):193–205. doi: 10.1016/s0167-8140(86)80049-4. [DOI] [PubMed] [Google Scholar]
  22. Piver M. S., Lele S. B., Marchetti D. L., Emrich L. J. Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas. J Surg Oncol. 1988 Aug;38(4):233–239. doi: 10.1002/jso.2930380406. [DOI] [PubMed] [Google Scholar]
  23. Rosenberg S. A., Tepper J., Glatstein E., Costa J., Young R., Baker A., Brennan M. F., Demoss E. V., Seipp C., Sindelar W. F. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer. 1983 Aug 1;52(3):424–434. doi: 10.1002/1097-0142(19830801)52:3<424::aid-cncr2820520307>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  24. Schoenfeld D. A., Rosenbaum C., Horton J., Wolter J. M., Falkson G., DeConti R. C. A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma. Cancer. 1982 Dec 15;50(12):2757–2762. doi: 10.1002/1097-0142(19821215)50:12<2757::aid-cncr2820501211>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  25. Stewart L. A., Parmar M. K. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet. 1993 Feb 13;341(8842):418–422. doi: 10.1016/0140-6736(93)93004-k. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES